(1S,2S)-2-(TERT-BUTOXYCARBONYLAMINO) CYCLOHEXANECARBOXYLIC ACID, 95.0%, 5g

Fmoc-3-aminobenzoic acid, 98.0%, 25g

2-tert-Butoxycarbonylamino-4-methyl-oxazole-5-carboxylic acid, 95.0%, 1g

3-Fluorobenzenecarboximidamidehydrochloride, 95.0%, 25g

Cis-2-Phenyl-1,3-dioxan-5-ol, 95.0%, 1g

6-Bromo-2-methylisoquinolin-1(2H)-one, 95.0%, 250mg

1-N-Boc-3-Carbamoylpiperidine, 95.0%, 100g

Pyrimidine, 4,6-dichloro-2-(2-thienyl)-, 97%, 250mg

5-Oxo-1-(2,4,6-trimethyl-phenyl)-pyrrolidine-3-carboxylic acid, 95.0%, 250mg

(E)-3-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)aniline, 100mg

3-(4-morpholinylcarbonyl)-1H-1,2,4-triazol-5-amine, 95.0%, 5g

N-methylpyrrolidin-3-amine dihydrochloride, 98%, 5g

GC capillary column ROTI®Cap-624, 25 m, 0.20 mm, 1.10 µm, 1 Piece(s)